Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KETACANCER: Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC

NCT04459234 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04459234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04459234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KETACANCER: Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC
Lead sponsor
Centre Leon Berard
Phase
Observational
Overall status
Completed
Start date
February 2, 2021
Completion date
March 9, 2023
Enrollment
81 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chronic pain, neuropathic pain, opioid use